Report Detail
Global Favipiravir Supply, Demand and Key Producers, 2026-2032
- RnM4666838 |
- 22 January, 2026 |
- Global |
- 105 Pages |
- GIR |
- Pharma & Healthcare
The global Favipiravir market size is expected to reach $ 6.24 million by 2032, rising at a market growth of -21.5% CAGR during the forecast period (2026-2032).
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
The Favipiravir market has witnessed accelerated growth primarily due to the global urgency for effective antiviral therapies during outbreaks such as COVID-19. Its broad-spectrum activity against RNA viruses makes it a valuable candidate in pandemic preparedness plans. Several countries have approved Favipiravir for emergency or conditional use during viral outbreaks, boosting its visibility and adoption. Moreover, the drug's oral administration route offers ease of distribution and use, particularly in low-resource settings where intravenous treatments are less feasible. Continued investment in antiviral drug research, government stockpiling programs, and the rising incidence of emerging infectious diseases are expected to sustain demand for Favipiravir and similar oral antivirals in the foreseeable future.
Despite its potential, the Favipiravir market faces significant challenges. Clinical data regarding its efficacy for diseases beyond influenza, especially COVID-19, remains mixed, which has led to varied regulatory responses across different countries. Concerns over side effects such as teratogenicity limit its use among certain patient groups, particularly pregnant women. Additionally, the presence of more effective or better-studied antiviral drugs—like remdesivir, molnupiravir, and Paxlovid—creates intense competition in the antiviral space. Intellectual property issues and varying manufacturing standards across countries also affect the consistency of Favipiravir supply and global acceptance, complicating its market expansion.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market.
This report studies the global Favipiravir production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Favipiravir and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Favipiravir that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Favipiravir total production and demand, 2021-2032, (K Units)
Global Favipiravir total production value, 2021-2032, (USD Million)
Global Favipiravir production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Favipiravir consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Favipiravir domestic production, consumption, key domestic manufacturers and share
Global Favipiravir production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Favipiravir production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Favipiravir production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Favipiravir market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma, Hisun Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Favipiravir market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Favipiravir Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Favipiravir Market, Segmentation by Type:
Brand Drug
Generic Drug
Global Favipiravir Market, Segmentation by Application:
Influenza Viruses
COVID-19
Others
Companies Profiled:
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Key Questions Answered:
1. How big is the global Favipiravir market?
2. What is the demand of the global Favipiravir market?
3. What is the year over year growth of the global Favipiravir market?
4. What is the production and production value of the global Favipiravir market?
5. Who are the key producers in the global Favipiravir market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Favipiravir Introduction
- 1.2 World Favipiravir Supply & Forecast
- 1.2.1 World Favipiravir Production Value (2021 & 2025 & 2032)
- 1.2.2 World Favipiravir Production (2021-2032)
- 1.2.3 World Favipiravir Pricing Trends (2021-2032)
- 1.3 World Favipiravir Production by Region (Based on Production Site)
- 1.3.1 World Favipiravir Production Value by Region (2021-2032)
- 1.3.2 World Favipiravir Production by Region (2021-2032)
- 1.3.3 World Favipiravir Average Price by Region (2021-2032)
- 1.3.4 North America Favipiravir Production (2021-2032)
- 1.3.5 Europe Favipiravir Production (2021-2032)
- 1.3.6 China Favipiravir Production (2021-2032)
- 1.3.7 Japan Favipiravir Production (2021-2032)
- 1.3.8 India Favipiravir Production (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Favipiravir Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Favipiravir Major Market Trends
2 Demand Summary
- 2.1 World Favipiravir Demand (2021-2032)
- 2.2 World Favipiravir Consumption by Region
- 2.2.1 World Favipiravir Consumption by Region (2021-2026)
- 2.2.2 World Favipiravir Consumption Forecast by Region (2027-2032)
- 2.3 United States Favipiravir Consumption (2021-2032)
- 2.4 China Favipiravir Consumption (2021-2032)
- 2.5 Europe Favipiravir Consumption (2021-2032)
- 2.6 Japan Favipiravir Consumption (2021-2032)
- 2.7 South Korea Favipiravir Consumption (2021-2032)
- 2.8 ASEAN Favipiravir Consumption (2021-2032)
- 2.9 India Favipiravir Consumption (2021-2032)
3 World Manufacturers Competitive Analysis
- 3.1 World Favipiravir Production Value by Manufacturer (2021-2026)
- 3.2 World Favipiravir Production by Manufacturer (2021-2026)
- 3.3 World Favipiravir Average Price by Manufacturer (2021-2026)
- 3.4 Favipiravir Company Evaluation Quadrant
- 3.5 Industry Rank and Concentration Rate (CR)
- 3.5.1 Global Favipiravir Industry Rank of Major Manufacturers
- 3.5.2 Global Concentration Ratios (CR4) for Favipiravir in 2025
- 3.5.3 Global Concentration Ratios (CR8) for Favipiravir in 2025
- 3.6 Favipiravir Market: Overall Company Footprint Analysis
- 3.6.1 Favipiravir Market: Region Footprint
- 3.6.2 Favipiravir Market: Company Product Type Footprint
- 3.6.3 Favipiravir Market: Company Product Application Footprint
- 3.7 Competitive Environment
- 3.7.1 Historical Structure of the Industry
- 3.7.2 Barriers of Market Entry
- 3.7.3 Factors of Competition
- 3.8 New Entrant and Capacity Expansion Plans
- 3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
- 4.1 United States VS China: Favipiravir Production Value Comparison
- 4.1.1 United States VS China: Favipiravir Production Value Comparison (2021 & 2025 & 2032)
- 4.1.2 United States VS China: Favipiravir Production Value Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States VS China: Favipiravir Production Comparison
- 4.2.1 United States VS China: Favipiravir Production Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Favipiravir Production Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States VS China: Favipiravir Consumption Comparison
- 4.3.1 United States VS China: Favipiravir Consumption Comparison (2021 & 2025 & 2032)
- 4.3.2 United States VS China: Favipiravir Consumption Market Share Comparison (2021 & 2025 & 2032)
- 4.4 United States Based Favipiravir Manufacturers and Market Share, 2021-2026
- 4.4.1 United States Based Favipiravir Manufacturers, Headquarters and Production Site (States, Country)
- 4.4.2 United States Based Manufacturers Favipiravir Production Value (2021-2026)
- 4.4.3 United States Based Manufacturers Favipiravir Production (2021-2026)
- 4.5 China Based Favipiravir Manufacturers and Market Share
- 4.5.1 China Based Favipiravir Manufacturers, Headquarters and Production Site (Province, Country)
- 4.5.2 China Based Manufacturers Favipiravir Production Value (2021-2026)
- 4.5.3 China Based Manufacturers Favipiravir Production (2021-2026)
- 4.6 Rest of World Based Favipiravir Manufacturers and Market Share, 2021-2026
- 4.6.1 Rest of World Based Favipiravir Manufacturers, Headquarters and Production Site (State, Country)
- 4.6.2 Rest of World Based Manufacturers Favipiravir Production Value (2021-2026)
- 4.6.3 Rest of World Based Manufacturers Favipiravir Production (2021-2026)
5 Market Analysis by Type
- 5.1 World Favipiravir Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 Brand Drug
- 5.2.2 Generic Drug
- 5.3 Market Segment by Type
- 5.3.1 World Favipiravir Production by Type (2021-2032)
- 5.3.2 World Favipiravir Production Value by Type (2021-2032)
- 5.3.3 World Favipiravir Average Price by Type (2021-2032)
6 Market Analysis by Application
- 6.1 World Favipiravir Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Influenza Viruses
- 6.2.2 COVID-19
- 6.2.3 Others
- 6.3 Market Segment by Application
- 6.3.1 World Favipiravir Production by Application (2021-2032)
- 6.3.2 World Favipiravir Production Value by Application (2021-2032)
- 6.3.3 World Favipiravir Average Price by Application (2021-2032)
7 Company Profiles
- 7.1 ChemRar Group
- 7.1.1 ChemRar Group Details
- 7.1.2 ChemRar Group Major Business
- 7.1.3 ChemRar Group Favipiravir Product and Services
- 7.1.4 ChemRar Group Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.1.5 ChemRar Group Recent Developments/Updates
- 7.1.6 ChemRar Group Competitive Strengths & Weaknesses
- 7.2 Glenmark
- 7.2.1 Glenmark Details
- 7.2.2 Glenmark Major Business
- 7.2.3 Glenmark Favipiravir Product and Services
- 7.2.4 Glenmark Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.2.5 Glenmark Recent Developments/Updates
- 7.2.6 Glenmark Competitive Strengths & Weaknesses
- 7.3 Fujifilm
- 7.3.1 Fujifilm Details
- 7.3.2 Fujifilm Major Business
- 7.3.3 Fujifilm Favipiravir Product and Services
- 7.3.4 Fujifilm Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.3.5 Fujifilm Recent Developments/Updates
- 7.3.6 Fujifilm Competitive Strengths & Weaknesses
- 7.4 Dr. Reddy
- 7.4.1 Dr. Reddy Details
- 7.4.2 Dr. Reddy Major Business
- 7.4.3 Dr. Reddy Favipiravir Product and Services
- 7.4.4 Dr. Reddy Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.4.5 Dr. Reddy Recent Developments/Updates
- 7.4.6 Dr. Reddy Competitive Strengths & Weaknesses
- 7.5 R-Pharma
- 7.5.1 R-Pharma Details
- 7.5.2 R-Pharma Major Business
- 7.5.3 R-Pharma Favipiravir Product and Services
- 7.5.4 R-Pharma Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.5.5 R-Pharma Recent Developments/Updates
- 7.5.6 R-Pharma Competitive Strengths & Weaknesses
- 7.6 Cipla
- 7.6.1 Cipla Details
- 7.6.2 Cipla Major Business
- 7.6.3 Cipla Favipiravir Product and Services
- 7.6.4 Cipla Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.6.5 Cipla Recent Developments/Updates
- 7.6.6 Cipla Competitive Strengths & Weaknesses
- 7.7 Lupin
- 7.7.1 Lupin Details
- 7.7.2 Lupin Major Business
- 7.7.3 Lupin Favipiravir Product and Services
- 7.7.4 Lupin Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.7.5 Lupin Recent Developments/Updates
- 7.7.6 Lupin Competitive Strengths & Weaknesses
- 7.8 Sun Pharma
- 7.8.1 Sun Pharma Details
- 7.8.2 Sun Pharma Major Business
- 7.8.3 Sun Pharma Favipiravir Product and Services
- 7.8.4 Sun Pharma Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.8.5 Sun Pharma Recent Developments/Updates
- 7.8.6 Sun Pharma Competitive Strengths & Weaknesses
- 7.9 Hisun Pharm
- 7.9.1 Hisun Pharm Details
- 7.9.2 Hisun Pharm Major Business
- 7.9.3 Hisun Pharm Favipiravir Product and Services
- 7.9.4 Hisun Pharm Favipiravir Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.9.5 Hisun Pharm Recent Developments/Updates
- 7.9.6 Hisun Pharm Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Favipiravir Industry Chain
- 8.2 Favipiravir Upstream Analysis
- 8.2.1 Favipiravir Core Raw Materials
- 8.2.2 Main Manufacturers of Favipiravir Core Raw Materials
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis
- 8.5 Favipiravir Production Mode
- 8.6 Favipiravir Procurement Model
- 8.7 Favipiravir Industry Sales Model and Sales Channels
- 8.7.1 Favipiravir Sales Model
- 8.7.2 Favipiravir Typical Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Favipiravir. Industry analysis & Market Report on Favipiravir is a syndicated market report, published as Global Favipiravir Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Favipiravir market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
